The role of elastin peptides in modulating the immune response in aging and age-related diseases

Pathologie Biologie

Volumn 60, Issue 1, 2012, Pages 28-33

  Fulop, T ^a   Khalil, A ^a   Larbi, A ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

Aging; Atherosclerosis; Elastin peptides; Immunosenescence; Inflamm aging; Innate and adaptive immune response

Indexed keywords

COLLAGEN; CYTOKINE; ELASTIN; TUMOR ANTIGEN;

ABDOMINAL AORTA ANEURYSM; AGING; ARTICLE; ATHEROSCLEROSIS; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSENESCENCE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION;

ADAPTIVE IMMUNITY; AGING; ANIMALS; DISEASE; ELASTIN; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MODELS, BIOLOGICAL; PEPTIDES;

EID: 84856960710     PISSN: 03698114     EISSN: 17683114     Source Type: Journal    
DOI: 10.1016/j.patbio.2011.10.006     Document Type: Article

References (92)

1. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
2. Candore G., Caruso C., Jirillo E., Magrone T., Vasto S. Low-grade inflammation as a common pathogenetic denominator in age-related diseases: novel drug targets for anti-ageing strategies and successful ageing achievement. Curr Pharm Des 2010, 16:584-596.
3. Miki C., Kusunoki M., Inoue Y., Uchida K., Mohri Y., Buckels J.A., et al. Remodeling of the immunoinflammatory network system in elderly cancer patients: implications of inflamm-aging and tumor-specific hyperinflammation. Surg Today 2008, 38:873-878.
4. Desai A., Grolleau-Julius A., Yung R. Leukocyte function in the aging immune system. J Leukoc Biol 2010, 87:1001-1009.
5. Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr Opin Immunol 2010, 22:507-513.
6. Fulop T, Fortin C, Lesur O, Dupuis G, Lord JM, Larbi A. The innate immune system and aging: what is the contribution to immunosenescence. Open Longevity, in press.
7. Peters T., Weiss J.M., Sindrilaru A., Wang H., Oreshkova T., Wlaschek M., et al. Reactive oxygen intermediate-induced pathomechanisms contribute to immunosenescence, chronic inflammation and autoimmunity. Mech Ageing Dev 2009, 130:564-587.
8. Khansari N., Shakiba Y., Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009, 3:73-80.
9. Derhovanessian E., Larbi A., Pawelec G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr Opin Immunol 2009, 21:440-445.
10. De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005, 579:2035-2039.
11. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009, 19:47-56.
12. Antonicelli F., Bellon G., Debelle L., Hornebeck W. Elastin-elastases and inflamm-aging. Curr Top Dev Biol 2007, 79:99-155.
13. Djekic U.V., Gaggar A., Weathington N.M. Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther 2009, 121:132-146.
14. Brusselle G.G., Demoor T., Bracke K.R., Brandsma C.A., Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful?. Eur Respir J 2009, 34(1):219-230.
15. Robert L., Robert A.M., Jacotot B. Elastin-elastase-atherosclerosis revisited. Atherosclerosis 1998, 140:281-295.
16. O'Reilly P.J., Gaggar A., Blalock J.E. Interfering with extracellular matrix degradation to blunt inflammation. Curr Opin Pharmacol 2008, 8:242-248.
17. Svitkina T.M., Parsons D.F. Binding of some metastatic tumor cell lines to fibrous elastin and elastin peptides. Int J Cancer 1993, 53:824-828.
18. Jung S., Rutka J.T., Hinek A. Tropoelastin and elasttin degradation products promote proliferation of human astrocytoma cell lines. J Neuropathol Exp Neurol 1998, 57:439-448.
19. Brassart B., Randoux A., Hornebeck W., Emmonard H. Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides in human HT-1080 fibrosarcoma cell line. Clin Exp Metastasis 1998, 16:489-5000.
20. Fülöp T., Jacob M.P., Robert L. Biological effects of elastin peptides. Elastin and elastases 1989, 1:201-210. CRC Press, Boca Raton.
21. Robert L. Aging of vascular wall and atherogenesis: Role of the elastin-laminine receptor. Atherosclerosis 1996, 123:169-179.
22. Fülöp TJr, Jacob M.P., Khalil A., Wallach J., Robert L. Biological effects of elastin peptides. Pathol Biol 1998, 46:497-506.
23. Tang E.H., Shvartz E., Shimizu K., Rocha V.Z., Zheng C., Fukuda D., et al. Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 2011, 31:261-269.
24. Biron C.A. More things in heaven and earth: defining innate and adaptive immunity. Nat Immunol 2010, 11:1080-1082.
25. Grubeck-Loebenstein B., Wick G. The aging of the immune system. Annu Rev Immunol 2002, 80:248-290.
26. Douziech N., Seres I., Larbi A., Szikszay E., Roy P.M., Arcand M., et al. Modulation of human lymphocyte proliferative response with aging. Exp Gerontol 2002, 37:369-387.
27. Mocchegiani E., Giacconi R., Cipriano R., et al. Are zinc-bound metallothionein isoforms (I+II and III) involved in impaired thymulin production and thymic involution during ageing?. Immunity Aging 2004, 1:5-12.
28. Fulop T., Larbi A., Wikby A., Mocchegiani E., Hirokawa K., Pawelec G. Dysregulation of T-cell function in the elderly: scientific basis and clinical implications. Drugs Aging 2005, 22:589-603.
29. Larbi A., Dupuis G., Khalil A., Douziech N., Fortin C., Fulop T. Differential role of lipid rafts in the functions of CD4+ and CD8+ human T-lymphocytes with aging. Cell Signal 2006, 18:1017-1030.
30. Weiskopf D., Weinberger B., Grubeck-Loebenstein B. The aging of the immune system. Transplant Intern 2009, 22:1041-1050.
31. Fulop T., Larbi A., Douziech N., Fortin C., Guérard K.P., Lesur O., et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 2004, 3:217-226.
32. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., et al. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009, 30:325-333.
33. Plowden J., Renshaw-Hoelscher M., Engleman C., Katz J., Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell 2004, 3:161-167.
34. Fortin C.F., McDonald P.P., Lesur O., Fülöp T. Aging and neutrophils: there is still much to do. Rejuvenation Res 2008, 11:873-882.
35. Klein G., Ekblom P. Extracellular matrix composition during kidney development. Contrib Nephrol 1990, 80:17-31.
36. Zuckerman K.S. Composition and function of the extracellular matrix in the stroma of long-term bone marrow cell cultures. Kroc Found Ser 1984, 18:157-170.
37. Rosenbloom J. Elastin: relation of protein and gene structure to disease. Lab Invest 1984, 51(6):605-623.
38. Madri J.A., Marx M. Matrix composition, organization and soluble factors: modulators of microvascular cell differentiation in vitro. Kidney Int 1992, 41:560-565.
39. Balo J. Connective tissue changes in atherosclerosis. Int Rev Connect Tissue Res 1963, 1:241-306.
40. Robert L., Robert A.M. Elastin, elastase and arteriosclerosis. Frontiers of matrix biology 1980, 8:139-173. Karger, Basel.
41. Bizbiz L., Alpérovitch A., Robert L. Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study. Atherosclerosis 1997, 131:73-78.
42. Saulnier J.M., Hauck M., Fülöp T., Wallach J.M. Human aortic elastin from normal individuals and atherosclerotic patients: lipid and cation contents; susceptibility to elastolysis. Clin Chim Acta 1991, 200:129-136.
43. Hornebeck W., Potazman J.P., De Cremoux H., Bellon G., Robert L. Elastase-type activity of human serum. Its variation in chronic obstructive lung diseases and atherosclerosis. Clin Physiol Biochem 1983, 1:265-292.
44. Robert C., Lesty C., Robert A.M. Ageing of the skin: study of elastic fiber network modifications by computerized image analysis. Gerontology 1988, 34:291-296.
45. Fulop T., Wei S.M., Robert L., Jacob M.P. Determination of elastin peptides in normal and arteriosclerotic human sera by ELISA. Clin Physiol Biochem 1990, 8:273-282.
46. Thomas A.H., Edelman E.R., Stultz C.M. Collagen fragments modulate innate immunity. Exp Biol Med (Maywood) 2007, 232:406-411.
47. Jacob M.P., Hornebeck W., Lafuma C., Bernaudin J.F., Robert L., Godeau G. Ultrastructural and biochemical modifications of rabbit arteries induced by immunization with soluble elastin peptides. Exp Mol Pathol 1984, 41:171-190.
48. Robert L., Jacob M.P., Labat-Robert J. Cell-matrix interactions in the genesis of arteriosclerosis and atheroma. Effect of aging. Ann N Y Acad Sci 1992, 673:331-341.
49. Varga Z., Jacob M.P., Robert L., Csongor J., Fulop Age-dependent changes of K-elastin stimulated effector functions of human phagocytic cells: relevance for atherogenesis. Exp Gerontol 1997, 32:653-662.
50. Senior R.M., Griffin G.L., Mecham R.P. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980, 66:859-862.
51. Fulop TJr, Jacob M.P., Varga Zs, Foris G., Leovey A., Robert L. Effects of elastin peptides on human monocytes: Ca mobilization, stimulation of respiratory burst and enzyme secretion. Biochem Biophys Res Commun 1987, 141:92-97.
52. Jacob M.P., Fülöp T., Foris G., Robert L. Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells. Proc Natl Acad Sci U S A 1987, 84:995-999.
53. Varga Z., Kovács E.M., Paragh G., Jacob M.P., Robert L., Fülöp T. Effect of elastin peptides and N-formyl-methionyl-leucyl phenylalanine on cytosolic free calcium in polymorphonuclear leukocytes of healthy middle-aged and elderly subjects. Clin Biochem 1988, 21:127-130.
54. Hance K.A., Tataria M., Ziporin S.J., Lee J.K., Thompson R.W. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg 2002, 35:254-261.
55. Guo G., Gehle P., Doelken S., Martin-Ventura J.L., von Kodolitsch Y., Hetzer R., et al. Induction of macrophage chemotaxis by aortic extracts from patients with marfan syndrome is related to elastin binding protein. PLoS One 2011, 6:e20138.
56. Huet E., Brassart B., Wallach J., Debelle L., Haye B., Emonard H., et al. Effect of elastin peptides on the production of matrix metalloproteinase 2 by human skin fibroblasts in culture. J Soc Biol 2001, 195:165-172.
57. Alvira C.M., Guignabert C., Kim Y.M., Chen C., Wang L., Duong T.T., et al. Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease. Am J Pathol 2011, 178:1210-1220.
58. Fulop TJr, Varga Z., Jacob M.P., Robert L. Effects of Lithium on superoxyde production and intracellular free calcium mobilization in elastin peptide (kappa-elastin) and FMLP stimulated human polymorphonuclear leukocytes. Effect of aging. Life Sci 1997, 60:PL325-PL332.
59. Fortun A., Khalil A., Gagné D., Douziech N., Kuntz C., Jay-Gerin J.P., et al. Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 2001, 156:11-21.
60. Fulop T., Larbi A., Fortun A., Robert L., Khalil A. Elastin peptides induced oxidation of LDL by phagocytic cells. Pathol Biol (Paris) 2005, 53:416-423.
61. Hornebeck W., Emonard H. The cell-elastin-elastase(s) interacting triade directs elastolysis. Front Biosci 2011, 16:707-722.
62. Hornebeck W., Derouette J.C., Roland J., Châtelet F., Bouissou H., Robert L. Correlation between age, arteriosclerosis and elastinolytic activity of human aorta wall. C R Acad Sci Hebd Seances Acad Sci D 1976, 282:2003-2006.
63. Hinek A. Biological roles of the non-integrin elastin/laminin receptor. J Biol Chem 1996, 377:471-480.
64. Robert L. Interaction between cells and elastin, the elastin receptor. Connective Tissue Res 1999, 40:75-82.
65. Hinek A. Nature and the mutiple functions of the 67kDa elastin-laminin binding protein. Cell Adhesion Commun 1994, 2:185-193.
66. Mecham R.P., Hinek A., Griffin G.L., Senior R.M., Liotta L.A. The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. J Biol Chem 1989, 264:16652-16657.
67. Gasparini G., Barbaresch M., Boracchi P., Bevilacqua P., Verderio P., Dalla Palma P., et al. 67kDa laminin receptor expression adds prognostic information to intra-tumoral microvessel density in node negative breast cancer. Int J Cancer 1995, 60:604-610.
68. Fülöp TJr, Jacob M.P., Wallach J., Hauck M., Seres I., Varga Z., et al. Le récepteur de l'élastine-laminine. J Soc Biol 2001, 195:157-165.
69. Faury G., Garnier S., Weiss A.S., Wallach J., Fulop TJr, Jacob M.P., et al. Action of tropoelastin and synthetic elastin sequences on vascular tone and on free calcium level in human vascular endothelial cells. Circulation Res 1998, 82:328-336.
70. Varga Z., Jacob M.P., Robert L., Fülöp Identification and signal transduction mechanism of elastin peptide receptor in human leukocytes. FEBS Lett 1989, 258:5-8.
71. Fujimoto N., Tajima S., Ishibashi A. Elastin peptides induce migration and terminal differentiation of cultured keratinocytes via 67kDa elastin receptor in vitro; 67kDa elastin receptor is expressed in the keratinocytes eliminating elastic materials in elastosis perforans serpiginosa. J Invest Dermatol 2000, 11:633-639.
72. Hauck M., Seres I., Kiss I., Saulnier J., Mohacsi A., Wallach J., et al. Effects of synthesized elastin peptides on human leukocytes. Biochem Mol Biol Int 1995, 37:45-55.
73. Parsons D.F. Some tumor cell protein kinases activated by receptors as markers, including elastin receptors. Cancer Invest 1992, 13:629-636.
74. Fülöp TJr, Douziech N., Jacob M.P., Hauck M., Wallach J., Robert L. Age-related alterations in the signal transduction pathways of the elastin-laminine receptor. Pathol Biol 2001, 49:339-348.
75. Duca L., Debelle L., Debret R., Antonicelli F., Hornebeck W., Haye B. The elastin peptides-mediated induction of pro-collagenase-1 production by human fibroblasts involves activation of MEK/ERK pathway via PKA- and PI(3)K-dependent signaling. FEBS Lett 2002, 524:193-198.
76. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell Signal 2000, 12:1-13.
77. Toshyuki O., Brown G.E., Yaffe M.B. MAP kinase pathways activated by stress: the p38 MAPK pathway. Critical Care Med 2000, 28(Suppl.):N67-N77.
78. Peterszegi G., Texier S., Robert L. Human and helper memory lymphocytes exhibit an inducible elasti-laminin receptor. Int Arch Allergy Immunol 1997, 114:218-223.
79. Larbi A., Levesque G., Robert L., Gagné D., Douziech N., Fülöp T. Presence and active synthesis of the 67kDa elastin-receptor in human circulating white blood cells. Biochem Biophys Res Commun 2005, 332:787-792.
80. Peterszegi G., Robert A., Robert L. Presence of the elastin-laminin receptor on human activated lymphocytes. C R Acad Sci 1996, 319:799-803.
81. Peterszegi G., Texier S., Robert L. Cell death by overload of the elastin-laminin receptor on human activated lymphocytes protection by lactose and melibiose. Eur J Clin Invest 1999, 29:166-172.
82. Péterszegi G., Robert L. Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: necrosis and apoptosis. Biomed Pharmacother 1998, 52:369-377.
83. Péterszegi G., Mandet C., Texier S., Robert L., Bruneval P. Lymphocytes in human atherosclerotic plaque exhibit the elastin-laminin receptor: potential role in atherogenesis. Atherosclerosis 1997, 135:103-107.
84. Debret R., Antonicelli F., Theill A., Hornebeck W., Bernard P., Guenounou M., et al. Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler Thromb Vasc Biol 2005, 25(7):1353-1358.
85. Aikawa M., Libby P. Atherosclerotic plaque inflammation: the final frontier?. Can J Cardiol 2004, 20:631-634.
86. Xiong W., Zhao Y., Prall A., Greiner T.C., Baxter B.T. Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol 2004, 172:2607-2612.
87. Franco C., Hou G., Ahmad P.J., Fu E.Y., Koh L., Vogel W.F., et al. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circ Res 2008, 102:1202-1211.
88. Wikby A., Johansson B., Olsson J., Löfgren S., Nilsson B.O., Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol 2002, 37:445-453.
89. Olsson J., Wikby A., Johansson B., Löfgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121:187-201.
90. Libby P., Okamoto Y., Rocha V.Z., Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010, 74:213-220.
91. Packard R.R., Lichtman A.H., Libby P. Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 2009, 31:5-22.
92. Cybulsky M.I., Won D., Haidari M. Leukocyte recruitment to atherosclerotic lesions. Can J Cardiol 2004, 20(Suppl. B):24B-28B.